U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                                      SEC File Number 333-145999


                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                                  (Check One):

[X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR

For Period Ended: December 31, 2011
---------------------------------

    Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
---------------------------------

    If the  notification  relates to a portion of the filing  checked  above,
identify  the Item(s) to which the notification relates:  N/A
---------------------------------

Part I - Registrant Information
---------------------------------

Full Name of Registrant:  TransBiotec, Inc.

Former Name if Applicable:  N/A

Address of Principal Executive Office (Street and Number)

      3030 Old Ranch Parkway, Suite 350

City, State and Zip Code

      Seal Beach, CA 90740





---------------------------------
Part II - Rules 12b-25(b) and (c)
---------------------------------

     If the subject  report could not be filed  without  unreasonable  effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check box if appropriate)

[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;

[X] (b) The subject annual report, semi-annual report, or transition report or
portion thereof will be filed on or before the fifteenth calendar day following
the prescribed due date; or the subject quarterly report or transition report on
Form l0-Q or portion thereof will be filed on or before the fifth calendar day
following the prescribed due date; and

[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.

---------------------------------
Part III - Narrative
---------------------------------

     State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K,
10-Q, or N-SAR,  or the transition  report or portion thereof could not be filed
within the prescribed time period.

     The Company did not complete its financial statements in sufficient time so
as to allow the filing of the report by March 30, 2012. As a result,  additional
time is needed to file the report.

---------------------------------
Part IV - Other Information
---------------------------------

    (1) Name and telephone number of person to contact in regard to this
notification

           Will Hart                 (303)             839-0061
       -----------------        -------------  -------------------------
            (Name)               (Area Code)       (Telephone Number)

                                       2


    (2)  Have all other periodic reports
         required under Section 13 or 15(d)
         of the Securities Exchange Act of
         1934 during the preceding l2 months
         (or for such shorter period that
         the registrant was required to file
         such reports) been filed? If answer
         is no, identify report(s).                 [X] Yes  [ ] No

    (3)  Is it anticipated that any significant
         change in results of operations from
         the corresponding period for the last
         fiscal year will be reflected by the
         earnings statements to be included
         in the subject report or portion thereof?  [ ] Yes  [X] No

         If so: attach an explanation of the anticipated change, both
         narratively and quantitatively, and, if appropriate, state the reasons
         why a reasonable estimate of the results cannot be made.

                                TRANSBIOTEC, INC.
                  --------------------------------------------
                  (Name of Registrant as specified in charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.

Date: March 30, 2012                     By:/s/ Charles Bennington
                                            -----------------------------------
                                            Charles Bennington
                                            Principal Executive Officer


                                    ATTENTION

     Intentional  misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).


                                       3